Skip to content
healthcare.dev

MEDROXYPROGESTERONE ACETATE

NDC 62756-091, MEDROXYPROGESTERONE ACETATE, injection, suspension, from Sun Pharmaceutical Industries, Inc..

Product NDC
62756-091
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210761
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62756-091 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEDROXYPROGESTERONE ACETATE150 mg/mL

Pharmacologic classes

Progesterone Congeners [CS]; Progestin [EPC]

Package NDCNDC-11Package
62756-091-40627560091401 SYRINGE in 1 CARTON (62756-091-40) / 1 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/01e28bef-9758-40cf-a4ff-86ae9f4f5105

Use it

Look up 62756-091 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62756-091 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62756-091. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.